These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5353261)

  • 1. Correlation between the rate of dissolution and absorption of salicylamide from tablet and suspension dosage forms.
    Bates TR; Lambert DA; Johns WH
    J Pharm Sci; 1969 Dec; 58(12):1468-70. PubMed ID: 5353261
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Bioavailability of salicylamide from tablets.
    Mulley BA; Rye RM; Shaw P
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:150P. PubMed ID: 4150555
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissolution rates of caffeine and salicylamide from tablets.
    Nerlo H; Czarnecki W; Dul R
    Pol J Pharmacol Pharm; 1974; 26(5):549-53. PubMed ID: 4427817
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-Hydroxylation of salicylamide in mice.
    Howell SR; Kotkoskie LA; Dills RL; Klaassen CD
    J Pharm Sci; 1988 Apr; 77(4):309-13. PubMed ID: 3379587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of processing technique of different dosage forms on dissolution rate of caffeine and salicylamide.
    Nerlo H; Czarnecki W; Dul R
    Pol J Pharmacol Pharm; 1976; 28(4):361-7. PubMed ID: 981026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium salicylamide: relative bioavailability and subjective effects.
    Fleckenstein L; Mundy GR; Horovitz RA; Mazzullo JM
    Clin Pharmacol Ther; 1976 Apr; 19(4):451-8. PubMed ID: 1269196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of oral dosage forms of oxazepam--correlation with in vitro dissolution rate.
    Pilbrant A; Glenne PO; Sundwall A; Vessman J; Wretlind M
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):7-15. PubMed ID: 322447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biopharmaceutical aspects of the medicinal forms of cephalexin].
    Garsheva GB; Berezovskaia LN; Grakovskaia LK
    Antibiot Med Biotekhnol; 1987 Nov; 32(11):844-6. PubMed ID: 3439790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of pyrogen-induced fever on salicylamide metabolism in man.
    Song CS; Gelb NA; Wolff SM
    J Clin Invest; 1972 Nov; 51(11):2959-66. PubMed ID: 5080420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent drug metabolism during the absorptive phase.
    Barr WH; Aceto T; Chung M; Shukur M
    Rev Can Biol; 1973; 32():Suppl:33-42. PubMed ID: 4791683
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of route of administration on competitive drug biotransformation interaction: salicylamide-ascorbic acid interaction in rats.
    Houston JB; Levy G
    J Pharmacol Exp Ther; 1976 Aug; 198(2):284-94. PubMed ID: 948026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of sulfate formation in biotransformation of salicylamide in man.
    Levy G; Matsuzawa T
    J Pharm Sci; 1966 Feb; 55(2):222-3. PubMed ID: 5923280
    [No Abstract]   [Full Text] [Related]  

  • 14. Biopharmaceutical studies on factors affecting rate of absorption of drugs. I. Absorption of salicylamide in micellar solution.
    Yamada H; Yamamoto R
    Chem Pharm Bull (Tokyo); 1965 Nov; 13(11):1279-84. PubMed ID: 5864716
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide.
    Levy G; Yamada H
    J Pharm Sci; 1971 Feb; 60(2):215-21. PubMed ID: 5572442
    [No Abstract]   [Full Text] [Related]  

  • 16. Biowaiver monograph for immediate-release solid oral dosage forms: bisoprolol fumarate.
    Charoo NA; Shamsher AA; Lian LY; Abrahamsson B; Cristofoletti R; Groot DW; Kopp S; Langguth P; Polli J; Shah VP; Dressman J
    J Pharm Sci; 2014 Feb; 103(2):378-91. PubMed ID: 24382794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-dependent dissolution rate of nitrofurantoin from commercial suspensions, tablets, and capsules.
    Bates TR; Young JM; Wu CM; Rosenberg HA
    J Pharm Sci; 1974 Apr; 63(4):643-5. PubMed ID: 4828728
    [No Abstract]   [Full Text] [Related]  

  • 18. Limited capacity of jejunal segments to effect glucuronidation and sulphation of aspirin and salicylamide in rats.
    Iwamoto K; Watanabe J
    J Pharm Pharmacol; 1983 Dec; 35(12):821-2. PubMed ID: 6141248
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man.
    Levy G; Procknal JA
    J Pharm Sci; 1968 Aug; 57(8):1330-5. PubMed ID: 5677334
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of carbonated beverages and of an antiemetic containing carbohydrate and phosphoric acid on riboflavin bioavailability and salicylamide biotransformation in humans.
    Houston JB; Levy G
    J Pharm Sci; 1975 Sep; 64(9):1504-7. PubMed ID: 1185567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.